Hello, Guest!
 
 

 
 
  Objects Tiiips Categories
Lysolecithin
"Descrizione"
by Handy23 (4290 pt)
2026-Jan-08 10:06

Review Consensus: 10 Rating: 10 Number of users: 1
Evaluation  N. ExpertsEvaluation  N. Experts
1
  
6
  
2
  
7
  
3
  
8
  
4
  
9
  
5
  
10
  1

Lysolecithin – naturally derived emulsifier, composition, cosmetic uses, and safety notes

Synonyms: lysolecithin, hydrolyzed lecithin, lecithins, hydrolyzedlysophospholipid fraction from lecithin
INCI / functions: surfactant – emulsifying (co-emulsifier and emulsion stabilizer)

Definition

Lysolecithin is a functional raw material obtained via hydrolysis (often enzymatic) of lecithin, with partial conversion of phospholipids into lysophospholipids. From a compositional standpoint, the ingredient mainly contains lysophosphatidylcholine (LysoPC) and, depending on source and process, variable amounts of other lysophospholipids (e.g., lysophosphatidylethanolamine), residual non-hydrolyzed phospholipids, released fatty acids, and minor components typical of lecithins; the actual profile depends on origin (soy, sunflower, egg, or other), grade, and supplier specification. In cosmetics it is used primarily as an emulsifier/co-emulsifier and to support dispersion of oily phases in water, with potential use in delivery systems (e.g., lamellar/liposomal structures) depending on quality and formulation technology.

  • Food: used as an emulsifier/stabilizer (food grade; category- and specification-dependent positioning).

  • Cosmetics: surfactant-emulsifier, emulsion stability, sensorial and dispersion support; potential support to delivery systems (grade-dependent).

  • Medicine: possible technical use in formulation contexts or research (not equivalent to clinical indications).

  • Pharmaceutical: excipient/auxiliary for dispersing or carrier systems, subject to grade and applicable dossier.

  • Industrial use: surfactant/emulsifier in technical formulations and dispersion processes (sector-dependent).

The name defines the structure of the molecule

  • "Lys" comes from the word "lysis", meaning splitting or breaking. In this context, it indicates that one of the acyl chains of the original lecithin has been removed.
  • "Lecithin" is a generic term that refers to a variety of lipid compounds, mainly phosphatidylcholine, that are present in many plants and animals. It's a natural emulsifying agent.

Description of the raw materials used in its production.

  • Lecithin. This is a natural phospholipid primarily extracted from soy or eggs. It serves as the primary precursor for the production of lysolecithin.
  • Water. Used as a solvent and reaction medium.
  • Enzymes. Specific enzymes, like phospholipases, are used to hydrolyze lecithin to produce lysolecithin.

Step-by-step summary of its industrial chemical synthesis process. 

  • Mixture Preparation. Lecithin is dissolved in water to form a solution.
  • Enzymatic Hydrolysis. Enzymes are added to the lecithin solution, initiating the hydrolysis reaction.
  • Separation. Once the reaction is complete, the lysolecithin is separated from the mixture.
  • Purification. The lysolecithin is purified to remove any impurities.
  • Drying. The purified lysolecithin is dried to remove any remaining moisture.


Calories (energy value)

MetricValue
Energy value (100 g)~900 kcal (typical order of magnitude for lipid fractions)
Technical noteUsed at functional doses: energy impact on the finished product is negligible


Identification data and specifications

ParameterValue
INCI nameLysolecithin
EU database descriptionLecithins, hydrolyzed
CAS number (cosmetic/industrial use, “hydrolyzed lecithins”)85711-58-6
EC number288-318-8


Note on possible alternative identifiersDetail
“Lysolecithin” as a single molecule (laboratory use)in literature and catalogs it may refer to specific lysophosphatidylcholines with different CAS numbers
Practical approachfor cosmetic use, refer to the CAS/EC of the purchased grade (lot SDS/CoA)


Key constituents

ClassMain componentsTechnical note
LysophospholipidsLysoPC and analogs (grade-dependent)primary driver of emulsifying behavior and interfacial structures
Residual phospholipidsphosphatidylcholine and others (variable share)affects stability, sensorial profile, lamellar behavior
Fatty acids / minor componentstrace fractionscan affect odor/oxidation; manage quality and storage
Carrier (if supplied as a solution)water/glycerin/glycols (depending on grade)determines dosing on active solids


Functional role in formulation

FunctionWhat it does in the formulaOperational notes
Emulsifier / co-emulsifiersupports formation of oil-in-water emulsions and improves stabilityoften works synergistically with other emulsifiers and structuring lipids
Dispersion supportimproves wetting and fineness of the dispersed phaseuseful in systems with moderate lipid loads or “light” textures
Support to delivery systems (grade-dependent)may promote lamellar/vesicular organizationrequires dedicated development and time-stability verification


Formulation compatibility

System / variableCompatibilityControl notes
O/W emulsionsgenerally goodoptimize oil phase and co-emulsifiers to avoid hot/cold instability
Surfactant systems (rinse-off)often compatibleverify foam, clarity, and odor
Electrolytes/saltsto be assessedhigh salinity may influence viscosity and interfacial stability
Polymers/gelssensitivepotential viscosity/clarity shifts; test at 24–48 h and under thermal cycling
Preservativesto be verifiedcompatibility and challenge testing are essential on the finished product


Use guidelines (indicative)

ApplicationTypical rangeTechnical note
O/W creams/lotions0.2–2.0%adjust based on oil phase and overall emulsifier system
Serums/light textures0.1–1.0%useful as co-emulsifier or support for lamellar structures
Rinse-off cleansing0.1–1.0%assess foam, stability, and surfactant compatibility


Typical applications

  • Creams and lotions targeting a light texture and good spreadability.

  • Emulsions with improved stability and a “soft” sensorial profile.

  • Formulas where support to lamellar structures is desired (dedicated development).

  • Selected rinse-off systems as dispersion/stability support (case-by-case validation).

Quality, grades and specifications

ParameterDetail
Gradescosmetic; sometimes food/technical (different specifications)
Recommended controlsidentity and phospholipid profile, moisture, peroxide/oxidation index (if specified), microbiology (if supplied as a solution), color/odor
DocumentationCoA and SDS are essential to define origin, carrier, potential allergen traces, and storage requirements


Safety, regulation and environment

TopicOperational guidance
Safety profilegenerally suitable for cosmetic use at typical levels; manage possible individual irritation via finished-product assessment
Allergens / originif derived from soy or egg, manage potential trace considerations and supplier allergen documentation (especially for “free from” claims)
EU cosmeticsuse under general rules and GMP; always verify finished-product dossier
Environmentlipid-derived material: manage effluents/residues per good practice; prevent uncontrolled release


Formulation troubleshooting

IssuePossible causeCorrective actions
Emulsion separation/instabilityunbalanced emulsifier system or incompatible oil phaseincrease co-emulsifiers, optimize structuring lipids, adjust process (shear/temperature)
Haze or loss of claritypolymer interaction or high salinityreduce electrolytes, change polymer, optimize pre-dispersion and addition order
Rancid odor over timeoxidation of lipid fractionsimprove oxidation control (compatible antioxidants), barrier packaging, cool storage
Viscosity drift at 24–48 hinterfacial/lamellar reorganizationstabilize with co-structurants, verify thermal cycling and maturation


Conclusion

Lysolecithin is a surfactant-emulsifying ingredient derived from hydrolyzed lecithin, particularly useful as a co-emulsifier in O/W emulsions and as support for dispersion and stability of aqueous systems containing lipid fractions. Performance depends critically on origin, grade, phospholipid profile, carrier (if supplied as a solution), and oxidation management, as well as on correct integration into the overall emulsifier system.

Lysolecithin  studies

Molecular Formula: C10H22NO7P

Molecular Weight: 299.26 g/mol

CAS       85711-58-6

EC Number:  288-318-8

Synonyms:

  • Lysophosphatidylcholine
  • L-ALPHA-LYSOPHOSPHATIDYLCHOLINE
  • 1-acetyl-sn-glycero-3-phosphocholine
  • [(2R)-3-acetyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
  • 3,5,9-Trioxa-4-phosphaundecan-1-aminium, 4,7-dihydroxy-N,N,N-trimethyl-10-oxo-, inner salt, 4-oxide, (R)-
References________________________________________________________________________
 

(1) Food and Drug Administration (FDA). Information supplied to FDA by industry as part of the VCRP FDA database.
2014. Washington, D.C.: FDA.

Lee HR, Kwon SY, Choi SA, Lee JH, Lee HS, Park JB. Valorization of Soy Lecithin by Enzyme Cascade Reactions Including a Phospholipase A2, a Fatty Acid Double-Bond Hydratase, and/or a Photoactivated Decarboxylase. J Agric Food Chem. 2022 Sep 7;70(35):10818-10825. doi: 10.1021/acs.jafc.2c04012.

Abstract. A huge amount of phospholipids or lecithin is produced as a byproduct in the vegetable oil industry. However, most are just used as a feed additive. This study has focused on enzymatic valorization of lecithin. This was exploited by enzymatic transformation of soy lecithin into lysolecithin liposomes, including functional free fatty acids, hydroxy fatty acids, hydrocarbons, or secondary fatty alcohols. One of the representative examples was the preparation of lysolecithin liposomes containing secondary fatty alcohols [e.g., 9-Hydroxyheptadec-11-ene (9) and 9-heptadecanol (10)] by using a phospholipase A2 from Streptomyces violaceoruber, a fatty acid double-bond hydratase from Stenotrophomonas maltophilia, and a photoactivated decarboxylase from Chlorella variabilis NC64A. The engineered liposomes turned out to range ca. 144 nm in diameter by dynamic light scattering analysis. Thereby, this study will contribute to application of functional fatty acids and their derivatives as well as valorization of lecithin for the food and cosmetic industries.

Cheng WJ, Yang HT, Chiang CC, Lai KH, Chen YL, Shih HL, Kuo JJ, Hwang TL, Lin CC. Deer Velvet Antler Extracts Exert Anti-Inflammatory and Anti-Arthritic Effects on Human Rheumatoid Arthritis Fibroblast-Like Synoviocytes and Distinct Mouse Arthritis. Am J Chin Med. 2022;50(6):1617-1643. doi: 10.1142/S0192415X22500689. 

Abstract. Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes joint deformity and disability. Deer velvet antler (DA), a traditional Chinese medicine, has been used to treat various types of arthritis for several thousands of years, but the underlying mechanisms are unknown. Herein, we investigated the anti-arthritic and anti-inflammatory effects of DA in vitro and in vivo. The ethyl acetate layer of DA ethanol extract (DA-EE-EA) was used to treat tumor necrosis factor (TNF)-[Formula: see text]-stimulated fibroblast-like synoviocyte MH7A cells, collagen-induced arthritis DBA/1 mice, and SKG mice with zymosan-induced arthritis. DA-EE-EA reduced nitric oxide production, prostaglandin E2 levels, and levels of pro-inflammatory cytokines including interleukin (IL)-1[Formula: see text], IL-6, and IL-8 in MH7A cells. DA-EE-EA also downregulated the phosphorylation of mitogen-activated protein kinase p38 and c-Jun N-terminal kinase and the translocation of nuclear factor kappa B p65. Intraperitoneal injection of DA-EE-EA for 3 weeks substantially reduced clinical arthritis scores in vivo models. Pathohistological images of the hind paws showed that DA-EE-EA reduced immune cell infiltration, synovial hyperplasia, and cartilage damage. The levels of pro-inflammatory cytokines, such as tumor necrosis factor alpha, IL-1[Formula: see text], IL-6, IL-8, IL-17A, and interferon-gamma, decreased in the hind paw homogenates of DA-EE-EA-treated mice. We also identified several potential components, such as hexadecanamide, oleamide, erucamide, and lysophosphatidylcholines, that might contribute to the anti-inflammatory effects of DA-EE-EA. In conclusion, DA-EE-EA has the potential to treat RA by regulating inflammatory responses. However, the individual components of DA-EE-EA and the underlying anti-inflammatory mechanisms need further investigation in future studies.

Evaluate